메뉴 건너뛰기




Volumn 63, Issue 1, 2012, Pages 87-90

Predictors of relapse in the year after hospital discharge among patients with schizophrenia

(20)  Schennach, Rebecca a   Naber, Dieter f   Rüther, Eckart m   Obermeier, Michael a   Schmidt, Lutz G g   Klingberg, Stefan n   Meyer, Sebastian a   Gaebel, Wolfgang h   Gastpar, Markus o   Jäger, Markus a   Klosterkötter, Joachim i   Seemüller, Florian a   Schmauss, Max c   Heuser, Isabella j   Möller, Hans Jürgen a   Laux, Gerd d   Maier, Wolfgang k   Riedel, Michael a,b   Pfeiffer, Herbert e   Lemke, Matthias R l  


Author keywords

[No Author keywords available]

Indexed keywords

NEUROLEPTIC AGENT;

EID: 84857851912     PISSN: 10752730     EISSN: 15579700     Source Type: Journal    
DOI: 10.1176/appi.ps.201100084     Document Type: Article
Times cited : (85)

References (14)
  • 1
    • 0035146082 scopus 로고    scopus 로고
    • Rehospitalization rates of chronically ill schizophrenic patients discharged on a regimen of risperidone, olanzapine, or conventional antipsychotics
    • DOI 10.1176/appi.ajp.158.2.266
    • Rabinowitz J, Lichtenberg P, Kaplan Z, et al: Rehospitalization rates of chronically ill schizophrenic patients discharged on a regimen of risperidone, olanzapine, or conventional antipsychotics. American Journal of Psychiatry 158:266-269, 2001 (Pubitemid 32116523)
    • (2001) American Journal of Psychiatry , vol.158 , Issue.2 , pp. 266-269
    • Rabinowitz, J.1    Lichtenberg, P.2    Kaplan, Z.3    Mark, M.4    Nahon, D.5    Davidson, M.6
  • 2
    • 76849096676 scopus 로고    scopus 로고
    • The cost of relapse and the predictors of relapse in the treatment of schizophrenia
    • Ascher-Svanum H, Zhu B, Faries DE, et al: The cost of relapse and the predictors of relapse in the treatment of schizophrenia. BMC Psychiatry 10:2, 2010
    • (2010) BMC Psychiatry , vol.10 , pp. 2
    • Ascher-Svanum, H.1    Zhu, B.2    Faries, D.E.3
  • 3
    • 0042978712 scopus 로고    scopus 로고
    • Relapse prevention in schizophrenia with new-generation antipsychotics: A systematic review and exploratory meta-analysis of randomized, controlled trials
    • DOI 10.1176/appi.ajp.160.7.1209
    • Leucht S, Barnes TR, Kissling W, et al: Relapse prevention in schizophrenia with new-generation antipsychotics: a systematic review and exploratory meta-analysis of randomized, controlled trials. American Journal of Psychiatry 160:1209-1222, 2003 (Pubitemid 41070936)
    • (2003) American Journal of Psychiatry , vol.160 , Issue.7 , pp. 1209-1222
    • Leucht, S.1    Barnes, T.R.E.2    Kissling, W.3    Engel, R.R.4    Correll, C.5    Kane, J.M.6
  • 4
    • 0346753734 scopus 로고    scopus 로고
    • Relapse and rehospitalization: Comparing oral and depot antipsychotics
    • Schooler NR: Relapse and rehospitalization: comparing oral and depot antipsychotics. Journal of Clinical Psychiatry 64(suppl 16):14-17, 2003
    • (2003) Journal of Clinical Psychiatry , vol.64 , Issue.SUPPL. 16 , pp. 14-17
    • Schooler, N.R.1
  • 6
    • 70450284576 scopus 로고    scopus 로고
    • The burden of depressive symptoms in people with schizophrenia
    • Conley RR: The burden of depressive symptoms in people with schizophrenia. Psychiatric Clinics of North America 32: 853-861, 2009
    • (2009) Psychiatric Clinics of North America , vol.32 , pp. 853-861
    • Conley, R.R.1
  • 8
    • 70349432151 scopus 로고    scopus 로고
    • Determinants of everyday outcomes in schizophrenia: The influences of cognitive impairment, functional capacity, and symptoms
    • Leifker FR, Bowie CR, Harvey PD: Determinants of everyday outcomes in schizophrenia: the influences of cognitive impairment, functional capacity, and symptoms. Schizophrenia Research 115:82-87, 2009
    • (2009) Schizophrenia Research , vol.115 , pp. 82-87
    • Leifker, F.R.1    Bowie, C.R.2    Harvey, P.D.3
  • 10
    • 33845658698 scopus 로고    scopus 로고
    • Prediction of remission as a combination of symptomatic and functional remission and adequate subjective well-being in 2960 patients with schizophrenia
    • Lambert M, Schimmelmann BG, Naber D, et al: Prediction of remission as a combination of symptomatic and functional remission and adequate subjective well-being in 2960 patients with schizophrenia. Journal of Clinical Psychiatry 67:1690-1697, 2006 (Pubitemid 44955148)
    • (2006) Journal of Clinical Psychiatry , vol.67 , Issue.11 , pp. 1690-1697
    • Lambert, M.1    Schimmelmann, B.G.2    Naber, D.3    Schacht, A.4    Karow, A.5    Wagner, T.6    Czekalla, J.7
  • 11
    • 67649908340 scopus 로고    scopus 로고
    • Achieving symptomatic remission in out-patients with schizophrenia: A naturalistic study with quetiapine
    • Wobrock T, Kohler J, Klein P, et al: Achieving symptomatic remission in out-patients with schizophrenia: a naturalistic study with quetiapine. Acta Psychiatrica Scandinavica 120:120-128, 2009
    • (2009) Acta Psychiatrica Scandinavica , vol.120 , pp. 120-128
    • Wobrock, T.1    Kohler, J.2    Klein, P.3
  • 12
    • 36849094016 scopus 로고    scopus 로고
    • Sociodemographic and clinical factors associated with relapse in schizophrenia
    • DOI 10.1111/j.1440-1819.2007.01722.x
    • Chabungbam G, Avasthi A, Sharan P: Sociodemographic and clinical factors associated with relapse in schizophrenia. Psychiatry and Clinical Neuroscience 61:587-593, 2007 (Pubitemid 350233479)
    • (2007) Psychiatry and Clinical Neurosciences , vol.61 , Issue.6 , pp. 587-593
    • Chabungbam, G.1    Avasthi, A.2    Sharan, P.3
  • 13
    • 77956444323 scopus 로고    scopus 로고
    • Low treatment adherence with antipsychotics is associated with relapse in psychotic disorders within six months after discharge
    • Laan W, Does YV, Sezgi B, et al: Low treatment adherence with antipsychotics is associated with relapse in psychotic disorders within six months after discharge. Pharmacopsychiatry 43:221-224, 2010
    • (2010) Pharmacopsychiatry , vol.43 , pp. 221-224
    • Laan, W.1    Does, Y.V.2    Sezgi, B.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.